US 7982011
Mutated anti-cd22 antibodies and immunoconjugates
granted A61KA61K47/6829A61K47/6849
Quick answer
US patent 7982011 (Mutated anti-cd22 antibodies and immunoconjugates) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K47/6829, A61K47/6849, A61P, A61P35/00